Association of Statin Therapy with Functional Outcomes and Survival in Intracerebral and Subarachnoid Hemorrhage

Bahadar S Srichawla1, Daksha Gopal1, Majaz Moonis1

  • 1Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.

Neurology International
|February 25, 2025
PubMed

Insights

Statin therapy, including low- and high-intensity, improved functional outcomes for patients with intracerebral hemorrhage (ICH). For subarachnoid hemorrhage (SAH) patients, statins may offer a survival benefit, suggesting neuroprotective effects in hemorrhagic stroke.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) are severe stroke types with significant morbidity and mortality.
  • Statins (HMG-CoA reductase inhibitors) possess lipid-lowering and potential neuroprotective/anti-inflammatory properties.

Purpose of the Study:

  • To evaluate the impact of statin therapy on functional outcomes and survival in patients with ICH and SAH.
  • To investigate the association between different statin intensities and stroke outcomes.

Main Methods:

  • Retrospective cohort study using the Get With The Guidelines (GWTG) stroke registry (January 2008 - June 2022).
  • Patients categorized into no statin, low-intensity statin, or high-intensity statin groups.
  • Primary outcome: Modified Rankin Scale (mRS) score at discharge (good: 0-2, poor: 3-6); multivariate logistic regression adjusted for age, gender, and NIHSS.

Main Results:

  • In ICH patients (n=663), both low-intensity (aOR 2.56) and high-intensity (aOR 2.445) statin therapy were significantly associated with good functional outcomes.
  • In SAH patients (n=159), all 39 deaths occurred in the no-statin group, suggesting a potential survival benefit.

Conclusions:

  • Both low- and high-intensity statin therapy are linked to improved functional outcomes in ICH.
  • Statin therapy may provide a survival benefit in SAH patients.
  • Findings suggest a potential neuroprotective role for statins in hemorrhagic stroke, warranting further investigation.